Get the Stockscreener App
7.5035
2.30%
-0.1765
After Hours:
7.14
-0.3635
-4.84%
Global X Genomics Biotechnology Etf stock is traded at $7.5035, with a volume of 121.53K.
It is down -2.30% in the last 24 hours and down -1.92% over the past month.
See More
Previous Close:
$7.68
Open:
$7.69
24h Volume:
121.53K
Relative Volume:
1.48
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-8.49%
1M Performance:
-1.92%
6M Performance:
-30.33%
1Y Performance:
-28.13%
1-Day Range:
$7.49
$7.79
1-Week Range:
$7.41
$8.24
52-Week Range:
$6.80
$11.88
Global X Genomics Biotechnology Etf Stock (GNOM) Company Profile
Name
Global X Genomics Biotechnology Etf
Sector
Industry
Phone
-
Address
-
Compare GNOM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GNOM
Global X Genomics Biotechnology Etf
|
7.5035 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
277.97 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
564.34 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
566.89 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
223.40 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
487.97 | 124.43B | 0 | 0 | 0 | 0.00 |
Global X Genomics Biotechnology Etf Stock (GNOM) Latest News
(GNOM) On The My Stocks Page - news.stocktradersdaily.com
Short Interest in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Drops By 75.5% - Defense World
Global X ETFs updates genomics fund index methodology By Investing.com - Investing.com South Africa
Global X ETFs updates genomics fund index methodology - Investing.com
The Next Big Theme: April 2025 - Global X ETFs
When (GNOM) Moves Investors should Listen - news.stocktradersdaily.com
Sei Investments Co. Takes $114,000 Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
American Century Companies Inc. Buys 3,841 Shares of TaskUs, Inc. (NASDAQ:TASK) - Defense World
Sei Investments Co. Invests $114,000 in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - The AM Reporter
GNOMComplete Genomics Reports Results for Second Quarter 2011 - ADVFN
Qiagen Shares Rise Premarket As Preliminary Q1 Results, Hikes FY25 EPS Guidance - Benzinga
Raymond James Financial Inc. Makes New Investment in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
(GNOM) Trading Advice - news.stocktradersdaily.com
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Purchased by Atria Investments Inc - Defense World
The Next Big Theme: March 2025 - Global X ETFs
SBI Securities Co. Ltd. Purchases Shares of 5,170 Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
(GNOM) Trading Signals - news.stocktradersdaily.com
Sanctuary Advisors LLC Takes $104,000 Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Illumina Inc. (ILMN): Navigating Trade Restrictions Amid Rising Competition - Value The Markets
(GNOM) Investment Analysis and Advice - news.stocktradersdaily.com
ETFs Tied to S 500 Top Performers Show Mixed Results - Yahoo Finance
The Next Big Theme: February 2025 - Global X ETFs
Grid Metals (CVE:GRDM) Given a C$0.42 Price Target at Fundamental Research - Defense World
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Stake Reduced by Stratos Wealth Partners LTD. - Defense World
Top Canadian Genetics Stocks of 2025 - The Motley Fool Canada
The Next Big Theme: January 2025 - Global X ETFs
How To Trade (GNOM) - Stock Traders Daily
Stifel Financial Corp Reduces Stock Position in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Jane Street Group LLC Sells 16,550 Shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Learn to Evaluate (GNOM) using the Charts - Stock Traders Daily
Rockefeller Capital Management L.P. Acquires Shares of 18,186 Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Five Thematic Trends to Watch in 2025 - home.saxo
Best-Performing ETF Areas of Last Week - Yahoo Finance
Atria Investments Inc Invests $122,000 in Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) - Defense World
Top Tech ETFs Right Now - Benzinga
5 Small-cap Biotech ETFs to Watch - Investing News Network
The Next Big Theme: September 2024 - Global X ETFs
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
How To Avoid The Worst Sector ETFs 3Q24 - Forbes
The Next Big Theme: August 2024 - Global X ETFs
Investing in Nobel Prize Achievements – CRISPR For Precise Genetic Engineering - Securities.io
3 Gene Editing Stocks with Potential to Transform Medicine - InvestorPlace
BioTech & Genomics ETFs Shine Amid Sector Rotation - Trackinsight
The Next Big Theme: July 2024 - Global X ETFs
Biotech ETFs See Uptick Amid Positive Market Signs - Trackinsight
The 3 Best Gene Editing Stocks to Buy in July 2024 - InvestorPlace
4 Up-and-Coming Small-Cap Biotech Stocks to Watch - Investing.com
7 Best Biotech ETFs to Buy Now - US News Money
The Next Big Theme: June 2024 - Global X ETFs
9 Best Biotech ETFs for 2024 - MSN
The Next Big Theme: May 2024 - Global X ETFs
Global X Genomics Biotechnology Etf Stock (GNOM) Financials Data
There is no financial data for Global X Genomics Biotechnology Etf (GNOM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.17%
0.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):